Magnetic resonance spectroscopy for evaluation of suspected brain tumor
BlueCross BlueShield Association
Record ID 32003000771
English
Authors' objectives:
This Assessment examines the available evidence to determine whether magnetic resonance spectroscopy (MRS) provides additional diagnostic information that improves the management and outcomes of patients who are being evaluated for brain tumor.
Authors' methods:
Systematic review
Details
Project Status:
Completed
URL for project:
http://www.bcbs.com/blueresources/tec/contact-tec.html
Year Published:
2003
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Magnetic Resonance Spectroscopy
- Brain Neoplasms
Contact
Organisation Name:
BlueCross BlueShield Association
Contact Address:
BlueCross BlueShield Association, Technology Evaluation Center, 225 North Michigan Ave, Chicago, Illinois, USA. Tel: 888 832 4321
Contact Name:
tec@bcbsa.com
Contact Email:
tec@bcbsa.com
Copyright:
BlueCross BlueShield Association (BCBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.